ArticleProstate cancer and prostatic diseases2022

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer.

Miguel Gonzalez Velez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.